Gene: ZNF385C
Official Full Name: zinc finger protein 385Cprovided by HGNC
Gene Summary: Predicted to enable nucleic acid binding activity and zinc ion binding activity. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37600 | ZNF385C Knockout cell line (HEK293) | Human | ZNF385C | 1:3~1:6 | Negative | Online Inquiry |
ZNF385C Gene Knockout Cell Lines are a cutting-edge biological tool designed for the study of gene function and regulation in various physiological and pathological contexts. These cell lines utilize advanced CRISPR/Cas9 gene-editing technology to create precise deletions in the ZNF385C gene, which is known to play a critical role in cellular processes such as transcriptional regulation and cell differentiation. By inactivating ZNF385C, researchers can explore the gene's contributions to vital pathways and its potential implications in diseases, including cancer.
The key function of ZNF385C Gene Knockout Cell Lines lies in their ability to enable live-cell assays and functional studies, allowing scientists to observe the effects of gene loss on cellular behavior, signaling pathways, and gene expression profiles. When exposed to various stimuli or treatments, these cell lines facilitate the investigation of downstream effects and compensatory mechanisms that may arise from ZNF385C inactivation. This capability is invaluable in elucidating the biological mechanisms underlying complex conditions and identifying potential therapeutic targets.
In the realm of biomedical research, ZNF385C Gene Knockout Cell Lines have significant implications, having applications in cancer research, drug development, and gene therapy. By providing a reliable model to study gene function, these cell lines also serve as crucial tools for validating hypotheses and screening novel compounds for therapeutic efficacy. Researchers and clinicians benefit from the reproducibility and consistency of findings derived from these knockout models, which enhance the reliability of data and conclusions.
A distinctive advantage of ZNF385C Gene Knockout Cell Lines is their specificity and ease of use compared to traditional knockdown techniques, such as RNA interference. Unlike transient knockdown methods that may yield variable results, gene knockout provides a stable and permanent disruption, leading to more robust and interpretable experimental outcomes. Moreover, these cell lines are readily available, facilitating quick integration into ongoing research projects without the lengthy process of generating customized models.
For researchers and clinicians aiming to unravel the complexities of gene function with confidence, investing in ZNF385C Gene Knockout Cell Lines represents a strategic choice. The ability to study the nuanced roles of ZNF385C in health and disease enhances understanding and paves the way for innovative therapeutic strategies. As a leading company with expertise in genomic technologies and biological research products, we are dedicated to providing top-tier solutions that empower scientists in their quest for discovery and clinical advancement.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.